Published research on Triclabendazole
1 peer-reviewed publication on Triclabendazole in oncology research, clinical work first, then laboratory studies. Each entry reports what the authors stated; follow the link for the full paper.
This page is a reading list of peer-reviewed publications, compiled for information. It is not a statement of indications, a recommendation or medical advice. Results from cell and animal studies do not translate into clinical use. Medsuvac products are supplied for their registered purposes; clinical decisions belong to a qualified physician.
- In vivo
Triclabendazole blocked PKM2 nuclear translocation via HDAC6-mediated deacetylation, reduced glycolytic flux, activated AMPK/mTOR signaling and suppressed proliferation of A549 and H1299 lung cancer cells, and inhibited tumor growth in nude mice.
Triclabendazole in the catalog (specifications, pack sizes, Certificate of Analysis)